Russia taps nanotech for drug production

Rusnano, the Russia Corporation of Nanotechnologies, is working to develop nanodrugs for cancer treatment. Its goal: Production facilities by 2014 for cancer-fighters with systems of targeted delivery--liposomes, immunoliposomes, and monoclonal antibodies. Release

Suggested Articles

Teva will produce its new migraine drug at a plant in Israel and more news of note.

The shortage of childhood cancer drug vincristine was front and center during the Senate hearing for Stephen Hahn, nominee for FDA commissioner.

The FDA has lambasted the Torrent Pharmaceuticals in a warning letter for making OTC meds using water tainted with bacteria.